Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Trends in Cardiovascular Medicine
|
November 5, 2003
Involvement of progenitor cells in vascular repair
Benjamin Hibbert, Steve Olsen, Edward O'Brien
The Psychiatric Quarterly
|
January 27, 2019
Missing Ingredients in Shared Decision-Making?
Anthony J Pavlo, Maria O'Connell, Steve Olsen, et al.
Current Oncology (Toronto, Ont.)
|
October 22, 2021
Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal <i>MET</i> Amplification from Aneuploidy in Diverse Advanced Cancers
Yuichi Kumaki, Steve Olsen, Mitsukuni Suenaga, et al.
JCO Precision Oncology
|
June 5, 2024
Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C-Mutant Non-Small Cell Lung Cancer: A Case Report
Chia-I Shen, Ju-Chen Chang, Suyog Jain, et al.
Journal of Wildlife Diseases
|
July 21, 2009
Pathogenesis and epidemiology of brucellosis in yellowstone bison: serologic and culture results from adult females and their progeny
Jack C Rhyan, Keith Aune, Thomas Roffe, et al.
Oncology Research and Treatment
|
May 5, 2025
Real-World Genomic Landscape of Gastrointestinal Cancers in Asia and the Middle East Using Comprehensive Circulating Tumor DNA Next-Generation Sequencing
Manabu Muto, Yu Sunakawa, Nippun Sandhir, et al.
Oncology
|
September 29, 2024
Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA in Routine Clinical Practice
Shaheenah Dawood, Nippun Sandhir, Marwan Akasheh, et al.
Clinical Pharmacokinetics
|
April 5, 2013
An integrated multiple-analyte pharmacokinetic model to characterize trastuzumab emtansine (T-DM1) clearance pathways and to evaluate reduced pharmacokinetic sampling in patients with HER2-positive metastatic breast cancer
Dan Lu, Amita Joshi, Bei Wang, et al.
Cancer Treatment and Research Communications
|
June 12, 2023
Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea
Beung-Chul Ahn, Seoyoung Lee, Jiyun Lee, et al.
Current Oncology (Toronto, Ont.)
|
March 24, 2022
Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice
Byoung Chul Cho, Herbert H F Loong, Chun-Ming Tsai, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Trends in Cardiovascular Medicine
|
November 5, 2003
Involvement of progenitor cells in vascular repair
Benjamin Hibbert, Steve Olsen, Edward O'Brien
The Psychiatric Quarterly
|
January 27, 2019
Missing Ingredients in Shared Decision-Making?
Anthony J Pavlo, Maria O'Connell, Steve Olsen, et al.
Current Oncology (Toronto, Ont.)
|
October 22, 2021
Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal <i>MET</i> Amplification from Aneuploidy in Diverse Advanced Cancers
Yuichi Kumaki, Steve Olsen, Mitsukuni Suenaga, et al.
JCO Precision Oncology
|
June 5, 2024
Afatinib Plus Bevacizumab Treatment for a Patient With EGFR S645C-Mutant Non-Small Cell Lung Cancer: A Case Report
Chia-I Shen, Ju-Chen Chang, Suyog Jain, et al.
Journal of Wildlife Diseases
|
July 21, 2009
Pathogenesis and epidemiology of brucellosis in yellowstone bison: serologic and culture results from adult females and their progeny
Jack C Rhyan, Keith Aune, Thomas Roffe, et al.
Oncology Research and Treatment
|
May 5, 2025
Real-World Genomic Landscape of Gastrointestinal Cancers in Asia and the Middle East Using Comprehensive Circulating Tumor DNA Next-Generation Sequencing
Manabu Muto, Yu Sunakawa, Nippun Sandhir, et al.
Oncology
|
September 29, 2024
Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA in Routine Clinical Practice
Shaheenah Dawood, Nippun Sandhir, Marwan Akasheh, et al.
Clinical Pharmacokinetics
|
April 5, 2013
An integrated multiple-analyte pharmacokinetic model to characterize trastuzumab emtansine (T-DM1) clearance pathways and to evaluate reduced pharmacokinetic sampling in patients with HER2-positive metastatic breast cancer
Dan Lu, Amita Joshi, Bei Wang, et al.
Cancer Treatment and Research Communications
|
June 12, 2023
Clinical utility of a plasma-based comprehensive genomic profiling test in patients with non-small cell lung cancer in Korea
Beung-Chul Ahn, Seoyoung Lee, Jiyun Lee, et al.
Current Oncology (Toronto, Ont.)
|
March 24, 2022
Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice
Byoung Chul Cho, Herbert H F Loong, Chun-Ming Tsai, et al.
Page
of 2